K2 Nytt

[:no]Velkommen til et CCBIO Special Seminar 19. september med tema «What is Scientific Excellence?»

CCBIO er et norsk senter for fremragende forskning. Men hva legger vi i begrepet fremragende? Én vanlig felles oppfatning er nærmest sirkulær: «Fremragende forskning er forskning som kan publiseres i fremragende tidsskrifter». Vi ønsker å gå dypere inn i begrepene kvalitetsforskning og fremragende forskning, og har invitert renommerte forskere som vil legge frem sine tanker om hva som bør ligge i disse begrepene, i seminaret «What is Scientific Excellence?». Programmet vil også gi plass til en paneldebatt. Foredragsholdere og deltakere i paneldebatten er Bruce Zetter (Harvard Medical School/Boston Children’s Hospital) og Merle Jacob (Universitetet i Lund) i tillegg til Lars A. Akslen og Roger Strand fra CCBIO.

Seminaret er en del av CCBIO/Harvard INTPART-samarbeidet, som et CCBIO Special Seminar i CCBIOs seminarserie.

Når: 19. september 2018, 13:00-16:00 (+ tid etterpå til pizza-sammenkomst)

Hvor: Auditorium 4, BB-bygget, på campus Haukeland Universitetssjukehus.

Program
13.00 Lars Akslen/Roger Strand: Welcome
13.05 Bruce Zetter: Thoughts on Excellence
13.30 Merle Jacob: Thoughts on Excellence
13.55 Lars Akslen: Thoughts on Excellence
14.05-14.30 Intermission with refreshments
14.30 Roger Strand: Introduction to debate
14.40-15.50: Panel debate with questions and comments from the audience
15.50-16.00: Lars Akslen: Concluding words

Åpent for alle: forskere, undervisere, postdocs, studenter, teknikere og andre ansatte, i alle UiB-miljøer. Ingen registrering er nødvendig.

Vi vet at alle fremragende hoder også trenger mat, så etter forelesningene og debatten inviterer vi til en pizza-sammenkomst i lobbyen utenfor auditoriet, der vi kan fortsette utvekslingen av ideer og erfaringer i en uformell setting.[:en]Welcome to a CCBIO Special Seminar September 19th with the title «What is Scientific Excellence».

CCBIO is a Norwegian Centre of Excellence. But what do we understand by excellence? One commonsensical notion is close to circular: «Excellent research is research that can be published in excellent journals». In this special seminar, we wish to go deeper into the issue of quality and excellence in science. Participants in the debate include Bruce Zetter (Harvard Medical School and Boston Children’s Hospital) and Merle Jacob (Lund University) as well as Lars A. Akslen and Roger Strand from the CCBIO.

The seminar is organized as part of the CCBIO/Harvard INTPART partnership, in the CCBIO Seminar series as a CCBIO Special Seminar.

When: 19. September 2018, 13:00-16:00 (+ time for pizza-get-together afterwards)

Where: Auditorium 4, BB-building, at Haukeland University Hospital campus.

Program
13.00 Lars Akslen/Roger Strand: Welcome
13.05 Bruce Zetter: Thoughts on Excellence
13.30 Merle Jacob: Thoughts on Excellence
13.55 Lars Akslen: Thoughts on Excellence
14.05-14.30 Intermission with refreshments
14.30 Roger Strand: Introduction to debate
14.40-15.50: Panel debate with questions and comments from the audience
15.50-16.00: Lars Akslen: Concluding words

Open for all: researchers, educators, postdocs, students, technicians and other staff, all over the UiB. No registration.

We know that all great minds also need food, so after the lectures and debate, we invite to a pizza-get-together in the lobby outside of the auditorium where we can continue the exchange of ideas and experiences.[:]

Open research seminar with speakers Michael Rogers and Bruce Zetter from Boston Children’s Hospital and Harvard Medical School. Michael Rogers’ talk: «Validation of Anthrax Toxin Receptor 2 (Antxr2/CMG2) as a Target for Small Molecule Antiangiogenic Therapy.» Bruce Zetter’s talk: «Drug discovery for treating metastatic cancers.»

Welcome to an open research seminar, hosted by CCBIO as part of the CCBIO/Harvard INTPART partnership, in the CCBIO Seminar series as a CCBIO Special Seminar.

The seminar is part of a 3 week course in Cancer-Related Vascular Biology, but as an open research seminar for those who would like to attend the lectures by our Harvard colleagues, but do not wish to follow the entire course. It is open for all, no registration, and no charge.

First speaker is Assistant Professor Michael Rogers from the Vascular Biology Program, Boston Children’s Hospital and Harvard Medical School.

Title: «Validation of Anthrax Toxin Receptor 2 (Antxr2/CMG2) as a Target for Small Molecule Antiangiogenic Therapy.»

Second speaker is Professor Bruce Zetter, Boston Children’s Hospital, and Charles Nowiszewski Professor of Cancer Biology, Surgery, Harvard Medical School.

Title: «Drug discovery for treating metastatic cancers.»

When: Thursday September 20th 09:00-12:00:

09:00-10:00 Michael Rogers

10:00-11:00 Coffee and discussion

11:00-12:00 Bruce Zetter

Where: Auditorium 4, BB-building, at Haukeland University Hospital campus.

You are all welcome!